Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
IPO Gives Kyverna Cash To Maintain Lead In Autoimmune CAR-T Development
With Metagenomi And Telomir, US Offerings Total Seven
Feb 09 2024
•
By
Mandy Jackson
Kyverna CEO Peter Maag was in New York for the company's IPO • Source: Kyverna Therapeutics Inc.
More from Financing
More from Business